January 11, 2017 article Open access Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice Journal of Biological Chemistry DOI: 10.1074/jbc.m116.767749 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 12 stored of 347 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access ACE2 decoy Fc-fusions and bispecific killer engagers require Fc engagement for in vivo efficacy against SARS-CoV-2 2026 The Journal of Immunology article Medicine SARS-CoV-2 and COVID-19 Research Open access 0 citations B Cell Subsets and Atherosclerosis: Updates and Emerging Concepts 2026 Immunological Reviews review Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access 2 citations Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing 2024 Communications Biology article Immunology and Microbiology HIV Research and Treatment Open access 17 citations ACE2 decoy Fc-fusions and bi-specific killer engager (BiKEs) require Fc engagement for in vivo efficacy against SARS-CoV-2 2024 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine SARS-CoV-2 and COVID-19 Research Open access 0 citations Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators 2024 Frontiers in Immunology article Immunology and Microbiology Complement system in diseases Open access cited by 1 patent 11 citations IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity 2024 Cancer Discovery article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent 77 citations Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation 2024 Cardiovascular Research article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access 25 citations Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation 2023 Proceedings of the National Academy of Sciences article Medicine Systemic Lupus Erythematosus Research Open access cited by 3 patents 18 citations Complement activation drives antibody-mediated transfusion-related acute lung injury via macrophage trafficking and formation of NETs 2023 Blood article Immunology and Microbiology Complement system in diseases Open access cited by 1 patent 51 citations MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression 2023 Frontiers in Immunology article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 5 patents 34 citations Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages 2022 Platelets article Medicine Blood groups and transfusion Open access 4 citations Therapeutic depletion of CCR8 + tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy 2021 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 26 patents 215 citations 12 results Cited by imported patents 1 (EPO, DOI in their cited literature) BISPECIFIC ANTIBODY AND USES THEREOF 2024 EP4551598A1 +2 publications Chemistry & metallurgy 3 offices References 0